Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin pharmacodynamics in breast cancer
NCT01763931Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2013
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin in breast cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2013; status: completed.
02
Drugs
digoxin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01763931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763931.